Skip to main navigation Skip to search Skip to main content

Hospitalist Buprenorphine Prescribing Before and After X-Waiver Removal at an Academic Center

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Studies on prescribing buprenorphine before and after buprenorphine training and the elimination of the X-waiver among hospitalists are limited. Objective: This study aims to determine hospitalists’ medication for opioid use disorder (MOUD) knowledge and beliefs before buprenorphine training and to assess MOUD prescribing patterns captured in the electronic medical record (EMR) pre-buprenorphine training, after training, and after elimination of the X-waiver. Design: Quantitative cohort survey study and quantitative retrospective medical record review. Participants: Hospitalists without an X-waiver before August 2022 (n = 70) at an academic hospital with a dedicated addiction consult service. Main Measures: For the survey, average composite scores of knowledge (higher score = more knowledge); for the EMR, MOUD inpatient, at discharge and ordering clinician specialty. Key Results: Fifty-four of 70 invited physicians (77.14%) completed the pre-training survey. The majority of participants provided counseling on MOUD (72.22%) before training, but only 46.3% initiated buprenorphine-naloxone, and 29.6% initiated methadone on patients with opioid use disorder (OUD) who were MOUD-naïve. The odds of a patient receiving an MOUD prescription at discharge post-training were higher than pre-training (OR = 1.69, [1.04, 2.70], p = 0.03). Having participated in the buprenorphine training was associated with greatly increased odds of prescribing buprenorphine at discharge (OR = 91.85, [28.17, 299.47], p < 0.001). The proportion of inpatient encounters with MOUD on their pre-hospitalization outpatient medication list that did not experience disruption of their MOUD during hospitalization increased over the three periods (82.05 to 83.64 to 93.33%; p < 0.001). Conclusions: Among a hospitalist group with high baseline MOUD knowledge, targeted buprenorphine training was associated with greater odds of prescribing buprenorphine. Fewer disruptions of the MOUD care continuum were observed over time which may reflect a combined impact of providing targeted education, changing federal policy change and having a dedicated addiction consult service.

Original languageEnglish
Number of pages8
JournalJournal of General Internal Medicine
DOIs
StateAccepted/In press - 2026

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Society of General Internal Medicine 2026.

Funding

This work was presented at the American Academy of Addiction Psychiatry (AAAP) Annual Meeting in December 2023. Travel to the conference was supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998 (Recipient: Rashmi Bharadwaj). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

FundersFunder number
National Center for Advancing Translational Sciences (NCATS)UL1TR001998

    Keywords

    • buprenorphine
    • opioid use disorder
    • prescribing patterns
    • x-waiver

    ASJC Scopus subject areas

    • Internal Medicine

    Fingerprint

    Dive into the research topics of 'Hospitalist Buprenorphine Prescribing Before and After X-Waiver Removal at an Academic Center'. Together they form a unique fingerprint.

    Cite this